These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29845418)

  • 21. Association between early palliative care referrals, inpatient hospice utilization, and aggressiveness of care at the end of life.
    Amano K; Morita T; Tatara R; Katayama H; Uno T; Takagi I
    J Palliat Med; 2015 Mar; 18(3):270-3. PubMed ID: 25210851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association between individual income and aggressive end-of-life treatment in older cancer decedents in Taiwan.
    Huang CY; Hung YT; Chang CM; Juang SY; Lee CC
    PLoS One; 2015; 10(1):e0116913. PubMed ID: 25585131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of healthcare expenditures with aggressive versus palliative care for cancer patients at the end of life: a cross-sectional study using claims data in Japan.
    Morishima T; Lee J; Otsubo T; Imanaka Y
    Int J Qual Health Care; 2014 Feb; 26(1):79-86. PubMed ID: 24225269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and Correlates of Increasing Use of Surgery in Taiwanese Cancer Patients' Last Month of Life, 2001-2010.
    Liu TW; Hung YN; Earle CC; Liu TP; Liu LN; Tang ST
    Ann Surg; 2016 Aug; 264(2):283-90. PubMed ID: 26655921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with aggressive end of life cancer care.
    Henson LA; Gomes B; Koffman J; Daveson BA; Higginson IJ; Gao W;
    Support Care Cancer; 2016 Mar; 24(3):1079-89. PubMed ID: 26253587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of age on end-of-life care for adult Taiwanese cancer decedents, 2001-2006.
    Tang ST; Liu TW; Shyu YI; Huang EW; Koong SL; Hsiao SC
    Palliat Med; 2012 Jan; 26(1):80-8. PubMed ID: 21606128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy Use in the Months Before Death and Estimated Costs of Care in the Last Week of Life.
    Garrido MM; Prigerson HG; Bao Y; Maciejewski PK
    J Pain Symptom Manage; 2016 May; 51(5):875-881.e2. PubMed ID: 26899821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?
    Xu YJ; Zheng H; Gao W; Jiang GN; Xie HK; Chen C; Fei K
    Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):887-93. PubMed ID: 25156899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. End-of-life Care Among Gynecological Oncology Patients in a Single Institute in Israel.
    Shapiro S; Lavie O; Schmidt M; Ben Arya E; Dagash J; Yosipovich A; Segev Y
    Isr Med Assoc J; 2021 Sep; 23(9):556-562. PubMed ID: 34472230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.
    Fletcher SA; Cronin AM; Zeidan AM; Odejide OO; Gore SD; Davidoff AJ; Steensma DP; Abel GA
    Cancer; 2016 Apr; 122(8):1209-15. PubMed ID: 26914833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
    Lee GW; Go SI; Cho YJ; Jeong YY; Kim HC; Duk Lee J; Hwang YS; Ko GH; Lee JH; Kim DC; Yang JW; Oh S; Lee JS
    J Thorac Oncol; 2012 Mar; 7(3):528-34. PubMed ID: 22258474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of post-progression survival on overall survival in elderly patients with extensive disease small-cell lung cancer.
    Imai H; Mori K; Watase N; Kazama T; Fujimoto S; Kaira K; Yamada M; Minato K
    Thorac Cancer; 2016 Nov; 7(6):655-662. PubMed ID: 27755823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small steps of improvement in small-cell lung cancer (SCLC) within two decades: a comprehensive analysis of 484 patients.
    Fiegl M; Pircher A; Waldthaler C; Gamerith G; Kocher F; Pall G; Nevinny M; Schmid T; Sterlacci W; Jamnig H; Zangerl G; Zabernigg A; Oberaigner W; Hilbe W
    Lung Cancer; 2014 May; 84(2):168-74. PubMed ID: 24646832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of end-of-life care between medical oncologists and other physician specialists for Taiwanese cancer decedents, 2001-2006.
    Liu TW; Chen JS; Wang HM; Wu SC; Hung YN; Tang ST
    Oncologist; 2009 Dec; 14(12):1232-41. PubMed ID: 20007642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide.
    Imai H; Mori K; Watase N; Fujimoto S; Kaira K; Yamada M; Minato K
    Can Respir J; 2016; 2016():5405810. PubMed ID: 27445549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trend in and Correlates of Undergoing Radiotherapy in Taiwanese Cancer Patients' Last Month of Life.
    Hung YN; Cheng SH; Liu TW; Chang WC; Chen JS; Tang ST
    J Pain Symptom Manage; 2016 Sep; 52(3):395-403. PubMed ID: 27265817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggressiveness of end-of-life care for patients with colorectal cancer in Alberta, Canada: 2006-2009.
    Hu W; Yasui Y; White J; Winget M
    J Pain Symptom Manage; 2014 Feb; 47(2):231-44. PubMed ID: 23870414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased aggressive care at the end of life among advanced cancer patients in the Republic of Korea: a nationwide study from 2012 to 2018.
    Kwon S; Kim K; Park B; Park SJ; Jho HJ; Choi JY
    BMC Palliat Care; 2024 Jun; 23(1):160. PubMed ID: 38918773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with not receiving homecare, end-of-life homecare, or early homecare referral among cancer decedents: A population-based cohort study.
    Bainbridge D; Seow H; Sussman J; Pond G; Barbera L
    Health Policy; 2015 Jun; 119(6):831-9. PubMed ID: 25497714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Third-line chemotherapy in small-cell lung cancer: an international analysis.
    Simos D; Sajjady G; Sergi M; Liew MS; Califano R; Ho C; Leighl N; White S; Summers Y; Petrcich W; Wheatley-Price P
    Clin Lung Cancer; 2014 Mar; 15(2):110-8. PubMed ID: 24365050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.